NCT07510633 A Mobile Brain/Body Imaging Platform for the Assessment and Optimization of Post-stroke Overground Robotic Gait Treatments
| NCT ID | NCT07510633 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Dr. Franco Molteni |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-05-06 |
| Primary Completion | 2027-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2025-05-06 with a primary completion date of 2027-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study aims to identify neural biomarkers that can be used to monitor the recovery of locomotion and movement of post-stroke patients, both in natural settings and with enriched treatment using robotic device. These biomarkers could potentially be utilized in clinical practice to improve recovery outcomes. Additionally, the study seeks to investigate whether it is feasible to use these biomarkers to predict the extent of recovery that patients may achieve.
Eligibility Criteria
Inclusion Criteria: * Age ≥18 years old * Stroke patients with different etiology: ischemic or hemorrhagic * Able to walk independently, eventually with aids/orthosis (FAC\>2) * Able to give the informed consent and to comprehend the instructions necessary to complete the task * Subject's anthropometric parameters adequate to wear the exoskeleton; * Body weight \< 90 kg; * Height 150 ÷ 192 cm; * Thigh lenght: 355 ÷ 475 mm; * Calf lenght: 405 ÷ 485 mm; * Hip width : 690 ÷ 990 mm; Exclusion Criteria: * Incapacity to give the informed consent and understand the tasks required * Fixed contracture at lower limbs that limits the use of the exoskeleton * Incapacity to walk independently (FAC\<=2) * Subject's anthropometric parameters not adequate to wear the exoskeleton
Contact & Investigator
Franco Molteni, MD
PRINCIPAL INVESTIGATOR
Villa Beretta Rehabilitation Center
Frequently Asked Questions
Who can join the NCT07510633 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07510633 currently recruiting?
Yes, NCT07510633 is actively recruiting participants. Contact the research team at fmolteni@valduce.it for enrollment information.
Where is the NCT07510633 trial being conducted?
This trial is being conducted at Costa Masnaga, Italy.
Who is sponsoring the NCT07510633 clinical trial?
NCT07510633 is sponsored by Dr. Franco Molteni. The principal investigator is Franco Molteni, MD at Villa Beretta Rehabilitation Center. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.